Characterizing fibroblast growth factor 21 through biophysical methods

by Hoang, J.; Thallapuranam, S. K. K.

Fibroblast growth factor 21 (FGF21) is a protein that acts similarly to hormones and affects metabolism. Its influence on fatty acid and glucose metabolism is what makes it a potential candidate for pharmaceutical use to treat metabolic diseases such as diabetes and obesity. FGF21 affects glucose metabolism via binding to obligate coreceptor ß-Klotho to FGF receptors on adipocytes to induce a signal cascade that upregulates transmembrane glucose transporter-1 (GLUT-1). The increased production of GLUT-1 allows for increased glucose intake from the bloodstream, reducing blood glucose levels. FGF21 has been shown to promote weight loss by improving glucose and lipid homeostasis and increasing insulin sensitivity and energy expenditure in animal models. However, FGF21 has a relatively unstable core and thus would not be biologically functional long enough for practical pharmaceutical use. Native FGF21 is prone is aggregation and degradation even while stored at -20°C. The purpose of this project is to purify recombinant FGF21 protein through a bacterial model and characterize this protein’s structure through biophysical methods. FGF21 was purified using immobilized metal affinity chromatography, specifically a Ni2+-Sepharose column. The FGF21 in the study was designed to have a 6-histidine tag with an affinity to Ni2+ and elute at 100 mM imidazole. The intrinsic fluorescence of FGF21 was found to be 304 nm, which indicates tyrosine emission. Circular dichroism of FGF21 showed a single negative trough at 215 nm, indicating the expected beta-sheet conformation of all FGFs’ beta-trefoil core. FGF21’s thermal melting temperature was found to be 44°C via differential scanning calorimetry. Limited trypsin digestion showed that FGF21 is prone to protease cleavages. These findings provide a crucial framework for developing novel structure-based variants of FGF21 with improved thermal stability while retaining the ability to modulate glucose levels.